IGDB.NSCLC Gene View
 
Gene Information        (help)
Gene KRT17 Ensembl ENSG00000186831 Chromosome 17 Start 37029218 End 37034355
Description Keratin, type I cytoskeletal 17 (Cytokeratin-17)(CK-17)(Keratin-17)(K17)(39.1) [Source:UniProtKB/Swiss-Prot;Acc:Q04695]

< Top >


Microarray Gene Expression Fold Change Result        (help)
( red: up-regulation / green : down-regulation when p value < 0.01)
( gray background : these probesets might have mapping problems. ref 1, ref 2)
Chip Type Probeset Adenocarcinoma Squamous Cell Carcinoma
Fold Change p value q value Fold Change p value q value
 HG_U95  34301_r_at  0.72  1.14e-6  7.39e-6  2.65  2.66e-18  1.70e-16
 HG_U133A  205157_s_at  2.02  1.37e-12  6.13e-12  2.72  5.75e-31  9.78e-31
 HG_U133A  212236_x_at  1.30  2.50e-11  1.01e-10  -3.24  5.30e-47  1.15e-46
 HG_U133_Plus2  205157_s_at  1.67  1.51e-7  7.79e-7  6.27  7.54e-43  2.51e-40
 HG_U133_Plus2  212236_x_at  1.57  2.51e-9  1.66e-8  5.63  5.37e-50  9.00e-47
 Stanford  13433  1.19  1.59e-1  3.37e-1  4.60  4.19e-9  2.59e-6
 Stanford  18725  1.12  2.27e-1  4.22e-1  4.59  1.66e-9  1.60e-6
 Agilent_HS_21.6K  3041  0.13  4.39e-1  6.22e-1  1.07  2.22e-9  8.36e-8

< Top >


Adjuvant Cisplatin/vinorelbine Treatment vs Observation Result        (help) (Pubmed)
( red: up-regulation / green : down-regulation when p value < 0.01)
( gray background color : the mapping problems of probeset. ref_1, ref_2)
Chip Type Probeset Adenocarcinoma Squamous Cell Carcinoma
Fold Change p value q value Fold Change p value q value
 HG_U133A  205157_s_at  0.28  7.83e-1  9.80e-1  -0.17  7.91e-1  1.00e+0
 HG_U133A  212236_x_at  0.61  3.76e-1  8.96e-1  0.06  8.97e-1  1.00e+0

< Top >


Microarray Sample Data        (help)
( The log2 value of tumor samples )
(Average : Average log2 value from Normal Samples.)
        HG_U95 - 34301_r_at    (back)       Save as a PNG file. Save as a PDF file. Save as a PS file.
Gene expression figure

        HG_U133A - 205157_s_at    (back)       Save as a PNG file. Save as a PDF file. Save as a PS file.
Gene expression figure

        HG_U133A - 212236_x_at    (back)       Save as a PNG file. Save as a PDF file. Save as a PS file.
Gene expression figure

        HG_U133_Plus2 - 205157_s_at    (back)       Save as a PNG file. Save as a PDF file. Save as a PS file.
Gene expression figure

        HG_U133_Plus2 - 212236_x_at    (back)       Save as a PNG file. Save as a PDF file. Save as a PS file.
Gene expression figure

        Stanford - 13433    (back)       Save as a PNG file. Save as a PDF file. Save as a PS file.
Gene expression figure

        Stanford - 18725    (back)       Save as a PNG file. Save as a PDF file. Save as a PS file.
Gene expression figure

        Agilent_HS_21.6K - 3041    (back)       Save as a PNG file. Save as a PDF file. Save as a PS file.
Gene expression figure

< Top >


Cancer Gene Index        (help)

If 0 entry was found, please remove the search key "lung cancer".
Keyword DiseaseData Statement PubMed Organism
k17 cysts Analysis of both phenotype and genotype data led to the following conclusions: (i) K6a or K16 mutations produce the pachyonychia congenita type 1 phenotype, whereas K17 (or K6b) mutations cause pachyonychia congenita type 2; (ii) the presence of pilosebac 11886499 Human
keratin 17 tumors We immunostained 142 lung tumors for B72.3, keratin 34betaE12, keratin 7, keratin 14, keratin 17, synaptophysin, and chromogranin to determine the utility of neuroendocrine markers and epithelial markers in the differential diagnosis. 10987260 Human
k17 tumors A complex keratin (K) pattern of stratified epithelia was typically seen in the SC tumors with extensive K7, K8, K17, K18, and K19, and variable K13 and K14 expression; EMA was also present. 11014583 Human
k17 carcinomas The GC carcinomas typically had K8 and K18, whereas the expression of K7 was variable and that of K14, K17, and K19 sporadic; EMA was variably present in half of the cases. 11014583 Human
k17 tumors Other keratins seen in the epithelia of biphasic tumors included K17 (variable, in 77%), K13 (25%), K16 (23%), and K6 (24%) in the minority of biphasic tumors, predominantly in stratified-appearing epithelia. 11037348 Human
k17 tumors The monophasic tumors showed limited positivity for complex epithelial keratins: K14 (28%) and K17 (10%). 11037348 Human
keratin 17 carcinomas In the overwhelming majority of carcinomas, cells did not contain myoepithelial markers (keratin 17 and vimentin) but expressed only keratin 8 specific to normal luminal epithelium. 2456993 Human
keratin 17 carcinomas The medians for keratin 17 were 0% in the normal group and 80% in carcinomas (p < 0.0001). 10343611 Human
keratin 17 cysts Based on the patterns of keratin 17 mRNA and neural cell adhesion molecule antigen expression, and on the distribution of alkaline phosphatase activity, we propose that dermal cysts in hr skin arise from (i) the central ORS, (ii) bulge-derived cells, or ( 9620297 Human
keratin 17 tumors Recently we demonstrated that the keratin 17 (K17) content exceeded the K16 content in most follicular tumors, in comparison with non-follicular epithelial skin tumours by two-dimensional gel electrophoresis (2-DE), densitometry and immunohistochemistry. 9651824 Human
k17 tumors Recently we demonstrated that the keratin 17 (K17) content exceeded the K16 content in most follicular tumors, in comparison with non-follicular epithelial skin tumours by two-dimensional gel electrophoresis (2-DE), densitometry and immunohistochemistry. 9651824 Human
keratin 17 tumours Recently we demonstrated that the keratin 17 (K17) content exceeded the K16 content in most follicular tumors, in comparison with non-follicular epithelial skin tumours by two-dimensional gel electrophoresis (2-DE), densitometry and immunohistochemistry. 9651824 Human
k17 tumours Recently we demonstrated that the keratin 17 (K17) content exceeded the K16 content in most follicular tumors, in comparison with non-follicular epithelial skin tumours by two-dimensional gel electrophoresis (2-DE), densitometry and immunohistochemistry. 9651824 Human
k17 tumor Immunohistochemical studies using frozen sections with chain-specific antikeratin monoclonal antibodies against K1, K7, K8, K10, K14, K16, K17, K18 and K19 showed that BCC tumor cells reacted positively with antibodies against K8, K14, K17 and K19, but di 9651824 Human
keratin 17 steatocystoma multiplex Keratin 17 mutations cause either steatocystoma multiplex or pachyonychia congenita type 2. 9767294 Human
k17 steatocystoma multiplex Previously, we have demonstrated that PC-2 is caused by mutations in K17 and that similar mutations in this gene can present as steatocystoma multiplex with little or no nail dystrophy. 9767294 Human
k17 steatocystoma multiplex These results demonstrate that K17 mutations commonly underlie both PC-2 and steatocystoma multiplex and that the alternate phenotypes which arise from these genetic lesions in K17 are independent of the specific mutation involved. 9767294 Human
keratin 17 steatocystoma multiplex Missense mutations in keratin 17 cause either pachyonychia congenita type 2 or a phenotype resembling steatocystoma multiplex. 9008238 Human
k17 steatocystoma multiplex We also show heterozygous missense mutations in K17 (N92H and R94H) in two families diagnosed as steatocystoma multiplex. 9008238 Human
k17 cysts Expression of keratins (K10 and K17) in steatocystoma multiplex, eruptive vellus hair cysts, and epidermoid and trichilemmal cysts. 9185910 Human
k17 steatocystoma multiplex Expression of keratins (K10 and K17) in steatocystoma multiplex, eruptive vellus hair cysts, and epidermoid and trichilemmal cysts. 9185910 Human
keratin 17 cysts We compared the patterns of keratin 10 (K10) and keratin 17 (K17) expression in epidermoid cysts, trichilemmal cysts, eruptive vellus hair cysts, and steatocystoma multiplex. 9185910 Human
k17 cysts We compared the patterns of keratin 10 (K10) and keratin 17 (K17) expression in epidermoid cysts, trichilemmal cysts, eruptive vellus hair cysts, and steatocystoma multiplex. 9185910 Human
keratin 17 steatocystoma multiplex We compared the patterns of keratin 10 (K10) and keratin 17 (K17) expression in epidermoid cysts, trichilemmal cysts, eruptive vellus hair cysts, and steatocystoma multiplex. 9185910 Human
k17 steatocystoma multiplex We compared the patterns of keratin 10 (K10) and keratin 17 (K17) expression in epidermoid cysts, trichilemmal cysts, eruptive vellus hair cysts, and steatocystoma multiplex. 9185910 Human
keratin 17 epidermoid cysts We compared the patterns of keratin 10 (K10) and keratin 17 (K17) expression in epidermoid cysts, trichilemmal cysts, eruptive vellus hair cysts, and steatocystoma multiplex. 9185910 Human
k17 epidermoid cysts We compared the patterns of keratin 10 (K10) and keratin 17 (K17) expression in epidermoid cysts, trichilemmal cysts, eruptive vellus hair cysts, and steatocystoma multiplex. 9185910 Human
k17 cysts Epidermoid cysts expressed K10 and eruptive vellus hair cysts expressed K17, whereas trichilemmal cysts and steatocystoma multiplex showed expression of both K10 and K17. 9185910 Human
k17 steatocystoma multiplex Epidermoid cysts expressed K10 and eruptive vellus hair cysts expressed K17, whereas trichilemmal cysts and steatocystoma multiplex showed expression of both K10 and K17. 9185910 Human
k17 epidermoid cysts Epidermoid cysts expressed K10 and eruptive vellus hair cysts expressed K17, whereas trichilemmal cysts and steatocystoma multiplex showed expression of both K10 and K17. 9185910 Human
k17 steatocystoma multiplex A family with affected members, previously reported to carry an R94H mutation of keratin K17, and characterized by a variable and oligosymptomatic form of pachyonychia congenita of the Jackson-Sertoli type with steatocystoma multiplex, is described in det 9267753 Human
k17 metaplasia K17 and K5/6 were present in cysts and squamous metaplasia of goitres, and focally in papillary but only exceptionally in follicular carcinoma in areas of squamous differentiation and tumour cells in desmoplastic stroma. 9428928 Human
k17 cysts K17 and K5/6 were present in cysts and squamous metaplasia of goitres, and focally in papillary but only exceptionally in follicular carcinoma in areas of squamous differentiation and tumour cells in desmoplastic stroma. 9428928 Human
k17 follicular carcinoma K17 and K5/6 were present in cysts and squamous metaplasia of goitres, and focally in papillary but only exceptionally in follicular carcinoma in areas of squamous differentiation and tumour cells in desmoplastic stroma. 9428928 Human
k17 tumour K17 and K5/6 were present in cysts and squamous metaplasia of goitres, and focally in papillary but only exceptionally in follicular carcinoma in areas of squamous differentiation and tumour cells in desmoplastic stroma. 9428928 Human
k17 steatocystoma multiplex K16 and K17 mutations have also been reported to produce phenotypes with little or no nail changes: K16 mutations can present as focal non-epidermolytic palmoplantar keratoderma (NEPPK) and K17 mutations can result in a phenotype resembling steatocystoma 9028791 Human
keratin 17 tumors Relative amounts of keratin 17 are higher than those of keratin 16 in hair-follicle-derived tumors in comparison with nonfollicular epithelial skin tumors. 7532196 Human
k17 tumors As a general rule, K6 and K16 were expressed in hyperproliferative conditions, such as epidermal tumors, and K17 was coexpressed in the same lesions. 7532196 Human
k17 tumors The ratio of K16 to K17 in many epithelial skin tumors has been unclear until now. 7532196 Human
k17 tumors K17 content exceeded K16 content in most follicular tumors, whereas in almost all the nonfollicular tumors and the psoriatic epidermis, K17 levels were less than or about equal to K16 levels. 7532196 Human
k17 tumors There was a significant difference in the ratio of K16 to K17 between follicular and nonfollicular skin tumors. 7532196 Human
keratin 17 squamous-cell carcinoma Therefore, the characteristic profile of squamous cell carcinoma was a strong and diffuse expression of keratin 14 and 16, strong but localized expression of keratin 17, and loss of keratin 13 expression. 7536179 Human
keratin 17 sebaceous cysts Keratin 17 mutation in pachyonychia congenita type 2 with early onset sebaceous cysts. 12653736 Human
keratin 17 sebaceous cysts CONCLUSIONS: Mutation in the 1A domain of keratin 17 underlies the affected members' phenotype, PC-2 with early onset sebaceous cysts and late-onset thickened fingernails and toenails. 12653736 Human
keratin 17 tumors Keratin 17 expression may prove prognostically helpful when assessing dysplasia in epidermal tumors. 7504888 Human
k17 squamous-cell carcinoma These include an expression of K16 in the uninvolved skin; K16 and K6 in Bowen's disease; and K16, K6 and K17 in squamous cell carcinoma and basal cell carcinoma. 7509818 Human
k17 basal-cell carcinoma These include an expression of K16 in the uninvolved skin; K16 and K6 in Bowen's disease; and K16, K6 and K17 in squamous cell carcinoma and basal cell carcinoma. 7509818 Human
k17 squamous-cell carcinoma K17 was expressed in squamous cell carcinoma and basal cell carcinoma, but not in Bowen's disease. 7509818 Human
k17 basal-cell carcinoma K17 was expressed in squamous cell carcinoma and basal cell carcinoma, but not in Bowen's disease. 7509818 Human
keratin 17 tumours Keratin 17, characteristic of the outer hair root sheath, was strongly expressed in all tumours. 1371396 Human
keratin 17 cervical intraepithelial neoplasia During progression of cervical intraepithelial neoplasia a clear increase in the expression of keratin 17 was observed. 1372156 Human
keratin 17 cervical cancer Lesions that lack expression of keratin 17 may form a distinct group, which are regressive in nature and do not progress into cervical cancer. 1372156 Human
keratin 17 carcinomas Keratin 17 may also be useful in distinguishing carcinomas of the cervix from those of the colon and also from mesotheliomas. 1379783 Human
keratin 17 intraductal carcinomas A similar reaction pattern was found with an antibody directed against keratin 17, although this antibody was more often found negative than keratin 14 in the pre-existing myoepithelial cells in intraductal carcinomas. 1705754 Human
k17 tumor Keratins were expressed in 11 of 13 tumors, and while specific keratins (K5, K7, K16/K17) decreased, there was an increase of vimentin in the tumor cells. 1712250 Mouse
k17 tumors Keratins were expressed in 11 of 13 tumors, and while specific keratins (K5, K7, K16/K17) decreased, there was an increase of vimentin in the tumor cells. 1712250 Human
k17 tumor It is shown here that normal cells produce keratins K5, K6, K7, K14, and K17, whereas tumor cells produce mainly keratins K8, K18, and K19. 1690428 Human
k17 bowen's disease These include an expression of K16 in the uninvolved skin; K16 and K6 in Bowen's disease; and K16, K6 and K17 in squamous cell carcinoma and basal cell carcinoma. 7509818 Human
k17 malignant tumors Both cells of the nontumorigenic HaCaT line and the tumorigenic HaCaT-ras clones, I-7 and II-3 (giving rise to benign and malignant tumors, respectively), constitutively expressed the keratins K5, K6, K14, K16 and K17, which are also common in cultures of 2472990 Human
k17 bowen's disease K17 was expressed in squamous cell carcinoma and basal cell carcinoma, but not in Bowen's disease. 7509818 Human
k17 epithelial skin tumors The ratio of K16 to K17 in many epithelial skin tumors has been unclear until now. 7532196 Human
k17 skin tumors There was a significant difference in the ratio of K16 to K17 between follicular and nonfollicular skin tumors. 7532196 Human
k17 hyperplastic Keratin 17 (K17) expression is currently considered to be associated with hyperplastic or malignant growth of epithelial cells. 9036933 Human
k17 epithelial skin tumours Recently we demonstrated that the keratin 17 (K17) content exceeded the K16 content in most follicular tumors, in comparison with non-follicular epithelial skin tumours by two-dimensional gel electrophoresis (2-DE), densitometry and immunohistochemistry. 9651824 Human
k17 bcc Immunohistochemical studies using frozen sections with chain-specific antikeratin monoclonal antibodies against K1, K7, K8, K10, K14, K16, K17, K18 and K19 showed that BCC tumor cells reacted positively with antibodies against K8, K14, K17 and K19, but di 9651824 Human
k17 bcc Predominant expression of K17 and the frequent expression of K8 and K19, with little K6/K16 and K1/K10 expression are the characteristic features of BCC, suggesting that BCC is differentiated towards undifferentiated follicular epithelia, most probably ha 9651824 Human
k17 cysts Using intradermal injection of a chimeric RNA-DNA oligonucleotide (RDO) or a single-stranded oligonucleotide (ssODN) into murine skin, we attempted to make a dominant mutation (R94p) in the conserve alpha-helical domain of keratin 17 (K17), the same mutat 14714564 Human
keratin 17 steatocystoma multiplex [Keratin 17 gene mutation in patients with steatocystoma multiplex] OBJECTIVE: To study the relationship between steatocystoma multiplex (SCM) and keratin 17 gene mutation. 11809119 Human
keratin 17 carcinomas of the cervix Keratin 17 may also be useful in distinguishing carcinomas of the cervix from those of the colon and also from mesotheliomas. 1379783 Human
keratin 17 bcc Antibodies to keratin 17 strongly stained cells of all BCC cases, and antibodies to keratin 8 reacted with most of them. 8721589 Human
keratin 17 epithelial skin tumors Relative amounts of keratin 17 are higher than those of keratin 16 in hair-follicle-derived tumors in comparison with nonfollicular epithelial skin tumors. 7532196 Human
keratin 17 epithelial skin tumours Recently we demonstrated that the keratin 17 (K17) content exceeded the K16 content in most follicular tumors, in comparison with non-follicular epithelial skin tumours by two-dimensional gel electrophoresis (2-DE), densitometry and immunohistochemistry. 9651824 Human
k17 basal cell carcinoma These include an expression of K16 in the uninvolved skin; K16 and K6 in Bowen's disease; and K16, K6 and K17 in squamous cell carcinoma and basal cell carcinoma. 7509818 Human
k17 squamous cell carcinoma These include an expression of K16 in the uninvolved skin; K16 and K6 in Bowen's disease; and K16, K6 and K17 in squamous cell carcinoma and basal cell carcinoma. 7509818 Human
k17 basal cell carcinoma K17 was expressed in squamous cell carcinoma and basal cell carcinoma, but not in Bowen's disease. 7509818 Human
k17 squamous cell carcinoma K17 was expressed in squamous cell carcinoma and basal cell carcinoma, but not in Bowen's disease. 7509818 Human
keratin 17 cin Furthermore the presence of keratin 17 in a CIN I, II, or III lesion may indicate progressive potential while its absence could be indicative of a regressive behavior. 1379783 Human
k17 non-epidermolytic palmoplantar keratoderma (neppk) K16 and K17 mutations have also been reported to produce phenotypes with little or no nail changes: K16 mutations can present as focal non-epidermolytic palmoplantar keratoderma (NEPPK) and K17 mutations can result in a phenotype resembling steatocystoma 9028791 Human
k17 epidermoid cysts We compared the patterns of keratin 10 (K10) and keratin 17 (K17) expression in epidermoid cysts, trichilemmal cysts, eruptive vellus hair cysts, and steatocystoma multiplex. 9185910 Human
k17 epidermoid cysts Epidermoid cysts expressed K10 and eruptive vellus hair cysts expressed K17, whereas trichilemmal cysts and steatocystoma multiplex showed expression of both K10 and K17. 9185910 Human
k17 epidermolytic palmoplantar keratoderma These include ichthyosis bullosa of Siemens (K2e), epidermolytic palmoplantar keratoderma (K1, K9), pachyonychia congenita (K6a, K6b, K16, K17), white sponge nevus (K4, K13), Meesmann's corneal dystrophy (K3, K12), cryptogenic cirrhosis (K8, K18) and 12688839 Human
k17 nevus These include ichthyosis bullosa of Siemens (K2e), epidermolytic palmoplantar keratoderma (K1, K9), pachyonychia congenita (K6a, K6b, K16, K17), white sponge nevus (K4, K13), Meesmann's corneal dystrophy (K3, K12), cryptogenic cirrhosis (K8, K18) and 12688839 Human
keratin 17 squamous cell carcinoma Therefore, the characteristic profile of squamous cell carcinoma was a strong and diffuse expression of keratin 14 and 16, strong but localized expression of keratin 17, and loss of keratin 13 expression. 7536179 Human
keratin 17 epidermoid cysts We compared the patterns of keratin 10 (K10) and keratin 17 (K17) expression in epidermoid cysts, trichilemmal cysts, eruptive vellus hair cysts, and steatocystoma multiplex. 9185910 Human
keratin 17 cin Keratin 17 was found in the majority of CIN lesions, irrespective of grade. 10227599 Human
keratin 17 hyperplastic Keratin 17 (K17) expression is currently considered to be associated with hyperplastic or malignant growth of epithelial cells. 9036933 Human
keratin 17 leukoplakia The use of complex phytoadaptogen in the treatment of patients with leukoplakia normalized expression of Fas-APO-1 antigen and keratin 17; increased expression of CD54 attested to activation of immune effectors. 16134819 Human
keratin 17 lung tumors We immunostained 142 lung tumors for B72.3, keratin 34betaE12, keratin 7, keratin 14, keratin 17, synaptophysin, and chromogranin to determine the utility of neuroendocrine markers and epithelial markers in the differential diagnosis. 10987260 Human
keratin 17 mesotheliomas Keratin 17 may also be useful in distinguishing carcinomas of the cervix from those of the colon and also from mesotheliomas. 1379783 Human
keratin 17 cysts Using intradermal injection of a chimeric RNA-DNA oligonucleotide (RDO) or a single-stranded oligonucleotide (ssODN) into murine skin, we attempted to make a dominant mutation (R94p) in the conserve alpha-helical domain of keratin 17 (K17), the same mutat 14714564 Human
k17 steatocystoma multiplex (sm) Missense mutations in human K17 give rise to two dominantly inherited disorders apparented to ectodermal dysplasias, pachyonychia congenita (PC), and steatocystoma multiplex (SM). 15102087 Human
krt17 dcis We also report the strong correlation in the breast epithelial SAGE libraries between the expression of S100A7 and genes reported as being up-regulated in DCIS, as well as in the inflammatory skin disorder, psoriasis; including RGS5, UPK1A, TMPRSS3, S100A 16273201 Human
k17 malignant tumor However, in clear contrast to the latter, transitional cells of the malignant tumor also strongly expressed the epithelial keratins K5, K14, and K17. 16441405 Human
keratin 17 steatocystoma multiplex Keratin 17 mutation in pachyonychia congenita type 2 patient with early onset steatocystoma multiplex and Hutchinson-like tooth deformity. 16620218 Human
keratin 17 steatocystoma multiplex In this report, we describe a missense mutation in the keratin 17 gene, M88T, in a Korean patient whose phenotype included early onset steatocystoma multiplex and Hutchinson-like tooth deformities along with other typical features of PC-2 such as hypertro 16620218 Human
k17 hyperplasia Hyperplasia-inducing agents (salicylic acid, croton oil) caused an increase in keratins K6, K16, and K17, but they did not effect filaggrin or alter proteolysis of stratum corneum keratins. 1370674 Human
k17 fibrosarcomas On the other hand, the cultured fibrosarcomas contained K8 and K18 in addition to the Ks present in the cultured fibroblasts, except K17. 12354414 Human
keratin-17 cyst The cyst epithelium contained keratin-15- and keratin-17-positive cells suggesting derivation from the hair follicle bulge and the presence of epithelial stem cells. 11564167 Human
k17 malignant transformation In a subset of the most severe OSF cases (14%), K17 expression was completely lost in the basal layer which might define them to be at most risk to undergo malignant transformation. 18205743 Human
krt17 tumor RESULTS: The mRNA levels of 8 (EGR1, p21, KRT17, PIM1, S100P, TNFRSF, WFDC2, and TRIM29) of 91 genes changed significantly with time of surgery in normal and tumor tissue. 17448597 Human
krt17 invasive human breast cancers WalBC cells exhibited expression of known markers of basal invasive human breast cancers as well as increased KRT17, KRT 14 and KRT 19, DSP, s100A4, NDRG-1, ANXA1, TK1 and AQP3 gene expression and decreased gene expression of TIMP3, VIM and TAGLN. 18179684 Human
k17 keratoacanthoma To clarify the histogenesis of keratoacanthoma, we studied keratin (K) expression in keratoacanthoma (KA) using 10 different anti-keratin antibodies against K1, K7, K8, K10, K14, K15, K16, K17, K18 and K19 and anti-filaggrin (filament aggregating protein) 18005116 Human
keratin 17 tumour METHODS AND RESULTS: Frozen tumour samples were analysed by real-time RT-PCR for the expression of ER, HER2, keratin 5 and keratin 17 genes. 18042072 Human
k17 steatocystoma multiplex Missense mutations in human K17 give rise to two dominantly inherited disorders apparented to ectodermal dysplasias, pachyonychia congenita (PC), and steatocystoma multiplex (SM). 15102087 Human
k17 non-epidermolytic palmoplantar keratoderma K16 and K17 mutations have also been reported to produce phenotypes with little or no nail changes: K16 mutations can present as focal non-epidermolytic palmoplantar keratoderma (NEPPK) and K17 mutations can result in a phenotype resembling steatocystoma 9028791 Human

< Top >


Download all image files.
Save all PNG files.    Save all PDF files.    Save all PS files.